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Objectives. We hypothesised that over the past decade, the nation-wide outcome of infrarenal abdominal aortic aneurysm
(AAA) repair has improved with the introduction of endovascular treatment. The aim of the study was to identify
endovascularly-treated patients in a national registry and to assess the impact on in-hospital mortality of non-ruptured
AAA repair, if any, after the introduction of endovascular repair.
Materials and methods. We retrospectively studied the nation-wide outcome of non-ruptured AAA repair over the past
decade. Variables studied were age and gender of the patients, hospital size and type and the year in which treatment was
performed and the outcome on in-hospital mortality. The in-hospital mortality of non-ruptured AAA repair in 16,446
patients in the 10-year period from 1991 to 2000 was 7.3% (6.2–8.2%). In the 15,589 (95%) patients that underwent
conventional treatment, in-hospital mortality was 7.6% (7.0–8.1%), whereas in the endovascular group it was 1.9% (0.6–
3.5%). In the multivariate analysis, age and endovascular repair were the most important independent predictors of in-
hospital mortality.
Conclusion. With the limitations of a national registry aside, the introduction of endovascular aneurysm repair seems to
have had a small but significant impact on in-hospital mortality following infrarenal AAA repair.
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Introduction
Elective repair of asymptomatic abdominal aortic
aneurysm (AAA), carries a mortality rate of between
5 and 10%. The goal of excluding the aneurysm prior
to the symptomatic stage, preceding rupture, is
obvious. The chance of rupture is proportional to the
diameter of the aneurysm, increasing markedly with
larger diameters.1 Despite incidentally reported excel-
lent figures on outcome following aortic aneurysm
surgery, the objective operative mortality is reflected
more accurately in population-based series. Although
single center studies on mortality following endovas-
cular AAA repair are available,2–4 to our knowledge
no population-based reports on mortality following
endovascular treatment of infrarenal AAAs have been
published.
We hypothesised that, over the past decade,
endovascular treatment has contributed to improved
results of non-ruptured AAA treatment.
In this study, we analysed nation-wide in-hospital
mortality of conventional open and endovascular
treatment of non-ruptured infrarenal aortic aneurysm
over the past decade in which endovascular repair was
introduced.
Materials and Methods
All patients admitted with the primary indication for
treatment of a non-ruptured infrarenal AAA in The
Netherlands from 1991 through to the year 2000 were
included in the study. Data were obtained from
Prismant—The Institute for Health Care Management
(Utrecht, The Netherlands). This is a national registry
for medical diagnoses and procedures. All hospitals in
The Netherlands where aortic aneurysm repair is
performed report to this national registration foun-
dation. Anonymous individual information was
obtained including the age and gender of the patients,
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date of treatment, hospital class (0–399 beds, $400
beds and university hospitals) and outcome of treat-
ment in (in-hospital) mortality.
Elective treatment of asymptomatic infrarenal
aortic aneurysm is not coded as such, but is included
in the broader group of ‘infrarenal AAA, without
mention of rupture’. Consequently, this code includes
impending rupture of symptomatic, but intact, aneur-
ysms. Emergency surgery for ruptured aneurysms
carries a different code.
The Prismant registry does not differentiate
between endovascular and conventional surgery. The
endovascular procedures in the study group were
identified using Eurostar and Medtronic records. The
Medtronic database was used because a few centers in
the Netherlands did not report to Eurostar. The vast
majority of the endografts used in these centers were
Medtronic devices. By combining the Eurostar and
Medtronic databases almost all endografts carried out
in the study-period were identified. For further
verification, institutional databases from selected
centers were individually analysed and subsequently
matched with the Prismant population database.
Eurostar is a European registry recording endovascu-
lar procedures performed in most European countries
and is an initiative of vascular surgeons. The Med-
tronic database is an industrial registry for endovas-
cular procedures.
Operative in-hospital mortality was defined as
death following treatment during hospital admission,
irrespective of the cause of death. For univariate
analysis, the ANOVA-test was used.
In-hospital mortality was also analysed using a
multiple linear regression analysis with stepwise,
backward removal of variables. The criterion of
removal used was a probability of F-to-remove
$0.100. Variables entered were the type (open versus
endovascular) and year of treatment, patient age,
gender, and hospital size and type. The statistical
package used was SPSS 11.01 for Windows.
Results
In the 10-year period from 1991 to 2000, 16,446 patients
underwent repair for a non-ruptured infrarenal AAA
in The Netherlands. There were 14,462 men (88%) and
1984 (12%) women. The overall in-hospital mortality
rate was 7.3% (1207 of 16,446 patients) and varied
between 6.2% in 1999 (101 of 1639 patients) and 8.2% in
1991 (123 of 1494 patients). Up to the year 1994, no
endovascular AAA repairs were performed in The
Netherlands. Beginning in 1994 the number of
endovascular aortic aneurysm repairs gradually
increased up to 277 per year in 2000 (Fig. 1). From
1994 through to the year 2000, a total of 857 patients
underwent endovascular infrarenal aortic aneurysm
repair. The average in-hospital mortality of endovas-
cular treatment was 1.9%, ranging from 0.6% in 1998
(one of 161 patients) to 3.5% in 2000 (10 of 287
patients). The average in-hospital mortality of con-
ventional treatment was 7.6% (1191 of 15,589 patients),
varying from 7.0% in 1999 (98 of 1397 patients) to 8.1%
in the year 2000 (104 out of 1283 patients).
In Fig. 2, the impact of the increasing number of
endovascular repairs can be appreciated by the
deviating mortality rates of all aneurysm repairs
versus conventional repairs.
Mortality for the different hospital classes was 6.5%
(95% confidence interval (CI): 5.7–7.4%) for the
category 0–399 beds, 7.6% (7.1–8.1%) for $400 beds
and 7.4% (6.3–8.6%) for University Hospitals (F ¼ 2:0;
p ¼ 0:13). Yearly differences of mortality between
hospital classes were considerable, but no significant
trends over time were found (Fig. 3).
Fig. 4 depicts the number of procedures in five age
groups for both males and females: 82% of the
procedures were performed on patients between 60
and 79 years of age. Mortality increased with age ðF ¼
8:4; p , 0:0005Þ (see Fig. 5). Overall in-hospital
mortality was 7.0% (95% CI: 6.6–7.4%) in men and
9.9% (95% CI: 8.6–11.2%) in women ðF ¼ 21:4; p ,
0:0005Þ: In all age categories, mortality in women was
than men, but only statistically significant for the age
category 60–69 years ðF ¼ 7:6; p ¼ 0:006Þ:
The multiple linear regression analysis (Table 1)
showed age and endovascular repair to be the most
important independent predictors of in-hospital mor-
tality. The year of operation was not statistically
significant.
Discussion
This nation-wide study indicates that the introduction
of endovascular treatment in 1994 has had an impact
on overall in-hospital mortality following intact infra-
renal AAA repair. Although the number of available
variables is limited, multivariate analysis incorporat-
ing age, gender, year and type of repair, and hospital
size and type supports this statement by showing that
type of repair, age, and gender are statistically
significant predictors of mortality and not the year of
operation. Data were obtained from Prismant, which is
a national registry for medical diagnoses and pro-
cedures. Obviously, only a limited number of possible
variables and trends can be analysed from a registry,
whereas operative mortality of aortic aneurysm repair
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has been demonstrated to correlate with several
cardiovascular risk factors.5,6 Moreover, this is a
descriptive retrospective study and not a randomised
trial. Patients treated endovascularly were entered into
this group because of the aorta anatomy, amongst
other reasons not specified, however, not randomly.
Despite these limitations, the impact of endovascular
repair seems obvious.
As has been described earlier, no information was
available on pre-operative risk factors like cardio-
vascular or pulmonary history and inflammatory or
symptomatic presentation of the aneurysm. In The
Netherlands it is not uncommon for high-risk
patients to be referred for treatment at University
Hospitals. However, apart from two individual
years (1995 and 1996), in which the effects were
complementary, hospital type and class did not
have a significant impact on in-hospital mortality in
the univariate analysis or in the multivariate
analysis.
Mortality increased with age. The group of patients
younger than 50 years comprises only 129 patients
(0.8%). In the subsequent age decades, an increase in
mortality is unmistakable and reflected in both
univariate and multivariate analysis. An identical
pattern is seen when analysing mortality in the
different age groups for both genders separately (Fig.
5). In all age groups, mortality in women exceeded that
Fig. 1. Number of intact infrarenal abdominal aortic aneurysm repairs performed in The Netherlands in the last decade
according to the type of treatment (conv, open surgical repair; endo, endovascular repair).
Fig. 2. In-hospital mortality in 16,446 patients following intact infrarenal abdominal aortic aneurysm repair over a decade,
regarding the entire studied group (All) and subdivided into the type of treatment performed (conv, open surgical repair;
endo, endovascular repair). Bars represent the 95% confidence intervals.
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in men. Again, this difference was significant in both
univariate and multivariate analysis.
The results of this study can be used in the
management of AAAs to help answer the question of
whether to repair or not to repair, although additional
variables need to be studied. This decision should be
the result of balancing the risk of rupture versus the
risk of operative treatment. The risk of rupture
increases with the diameter of the aneurysm. Ledere
et al. reported on a group of 198 veterans with an aortic
aneurysm over 5.5 cm that refused or were unfit for
elective repair.1 They found a 1-year rupture rate of
9.4% for aneurysms of 5.5–5.9 cm that increased to
32.5% for those over 7.0 cm. There is a large variation
in reported mortality following conventional aortic
aneurysm repair. In contrast to selective published
series of major vascular surgical centres, objective
mortality rates are reflected in population-based
series, including multicenter figures of operations
performed in all hospitals in a country.7,8 In a review
of publications between 1985 and 1996, Blankensteijn
et al. found a 30-day mortality for elective aortic
aneurysm repair of 7.4–8.2%.7 Moreover, the results of
the UK Small Aneurysm Trial showed a significant
higher mortality (5.8%) than expected in the design of
the study (2%).8
Hypothetically, mortality is reduced by the intro-
duction of endovascular repair. In the current study,
mortality in the group of 15,589 patients who under-
went conventional surgery was 7.6% (1191 patients),
Fig. 3. In-hospital mortality in 16,446 patients following intact infrarenal abdominal aortic aneurysm repair over a decade,
regarding the type of hospital in which treatment was performed (0–399 beds; $400 beds; University hospitals). Bars
represent the 95% confidence intervals.
Fig. 4. Number of abdominal aortic aneurysm repairs between 1991 and 2000 related to age and gender.
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whereas the overall mortality in the entire group of
16,446 patients, including endovascularly treated
patients, was 7.3% (1207 patients).
Undoubtedly, some selection bias will be in effect
leading to smaller and easier aneurysms having a
greater chance of being treated by endovascular
means. In our opinion, however, it is not to this extent
that the majority of endovascular repairs are per-
formed in patients with aneurysms less than 5.5 cm as
Collin and Murie suggest.9 It is more likely that an
opposite selection bias is also in effect by which older
and higher-risk patients, that are unsuitable for
conventional repair, are accepted for an endograft.
This would lead to a higher mortality rate in the
endovascular group. This might partially explain the
increase in mortality in the group who underwent
endovascular repair in the subsequent years, as the
indications of patients accepted for endovascular
treatment became less strict as experience with the
procedure increases.
For the same reasons of selection bias, the results of
this study cannot be used to promote endovascular
repair over conventional repair. The study merely
suggests that incorporating an endovascular program
can have a positive effect on population-based
mortality of AAA repair. It has to be taken into
account that in this study, in-hospital mortality was
analysed. Following discharge after endovascular
AAA repair several problems might still occur, even
rupture.10,11 These factors could not be included in this
study as they were not available in the registry.
Obviously this limitation may have had a positive
impact on the in-hospital mortality of endovascular
repair, although early ruptures are extremely rare, and
we are unaware of such early ruptures in the Nether-
lands. A further limitation of the registry is that it
documents data on non-ruptured AAA repair. Conse-
quently, this group included intact but symptomatic
aneurysms and the subgroup carried a higher mor-
tality. Still, the overall mortality did decline over a 10-
year period in which endovascular treatment was
introduced. Apart from mortality, other issues like
quality of life and cost-effectiveness must be taken into
account before the gold standard of conventional
aneurysm surgery can be replaced by endovascular
repair.
Randomised controlled trials are currently running
(theEVAR-trial in theUnitedKingdom, theDREAM-trial
Fig. 5.Mortality rate in 16,446 intact infrarenal abdominal aortic aneurysm repairs between 1991 and 2000 related to age and
gender. Bars represent the 95% confidence intervals.
Table 1. Multivariate analysis of 16,446 patients with intact infrarenal abdominal aortic aneurysm repair over the decade 1991–2000
Multiple linear regression analysis of 16,446 patients, R ¼ 0:159
Variable Parameters Beta T-value P-value
Age Years 0.146 18.885 0.000
Type of AAA repair 0: Conventional; 1: Endovascular 20.053 26.570 0.000
Type & size hospital 1: ,399; 2: $399 beds; 3: University Hospital 0.023 2.957 0.003
Gender 1: Male; 2: Female 0.021 2.737 0.006
Year of operation 1991–2000 20.008 21.006 0.314
(Constant) 214.342 0.000
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in the Netherlands and the OVER-trial in the USA).
Results of these trials are eagerly awaited.
With the limitations of a retrospective analysis of
national registry data in mind, we conclude that trends
over a decade seem to indicate that the introduction of
endovascular repair has had a small but significant
impact on overall in-hospital mortality following
intact infrarenal AAA repair.
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